Sexually transmitted infections (STIs) remain one of the most persistent global public health challenges. Over 1 million new infections occur daily, and cases of syphilis, gonorrhea, and chlamydia continue to rise globally.
🌍 Global STI Situation (2025–2026)
Antibiotic resistance is a growing threat. A new oral antibiotic (gepotidacin) has been introduced as a treatment for gonorrhea—the first new class of antibiotics in decades. Meanwhile, STI vaccine development remains complex, as seen in recent gonorrhea vaccine trials.
🧪 Emerging Prevention Strategies
Doxy-PEP: Studies show a ~65% reduction in STI risk in high-risk groups when taking antibiotics shortly after exposure (significantly reducing chlamydia and syphilis).
🛡️ What Still Works Best
- Condom use and regular STI screening
- Vaccination (HPV, Hepatitis B)
- Partner notification and treatment
